Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 rollover study of parsaclisib for advanced malignancies
2019-004948-30Phase 2Active
- Sponsor
- Incyte
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of parsaclisib in advanced cancer, mature B-cell lymphoma and cancer (2 arms), sponsored by Incyte. Primary endpoint: Safety (AEs and SAEs). Started Jun 2020; status: active.
02
Drugs
parsaclisib
03
Conditions
advanced cancermature B-cell lymphomacancer
Beyond the preview
Go deeper on 2019-004948-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004948-30.